SLC3A2 and familial pancreatic carcinoma: Further studies are needed to get better insights into the role of CD98hc in the pathogenesis and malignant cell transformation in pancreatic cancer, which may be the basis for the development of new targeted therapeutic approaches for this disease in the future.